Designed to be best in class.
Who it's all about.
We continuously engage with our customers to improve patient satisfaction.
Customer Satisfaction Survey Results
On average, customers responded with 99% product satisfaction. EMED is dedicated to developing products to serve patients and their infusion needs.
The essential nature of our products means we prioritize on-time delivery. We're always looking for ways to deliver our products effectively.
On average, customers replied with 98% customer service satisfaction. We are committed to providing the best service to keep customers satisfied.
OPTFlow Soft-Site Dressing Survey Results
Improvement of usability and patient comfort
94% of users reported that the new site dressing improves usability and patient comfort.
97% of users reported that the site dressing was easy to remove from the skin.
Over 90% of respondents recommend the Soft-Site to maximize patient comfort.
Trust the data.
OPTFlow and the SCIg60 Infuser work with a wide variety of immunoglobulin concentrations and viscosities.
OPTFlow Ig concentration range
OPTFlow IgG viscosity range
Viscosity (cP) Compatibility Range
Designed for Higher Flow Rates
EMED OPTFlow needle sets have been engineered with a specific needle curvature designed to deliver higher flow rates while incorporating the coating technology for lower penetration force. The design exceeds drug requirements for a wide range of immunoglobulins.
Time to explore flows and forces.
Flow Rate of 26ga Needle Sets
Flow rate (ml/hr)
EMED OPTFlow administration sets provide a solution for the increasing market demands of higher flow rates. EMED OPTFlow administration sets have higher maximum flow rates than subcutaneous device competitors.
Number of Injection Sites
Needle Penetration Force
EMED Soft-Glide needle design requires substantially less penetration force resulting in a virtually painless patient experience.
Average Penetration Force During Insertion
EMED Soft-Glide needle coating decreases penetration force by reducing friction between the needle surface and the skin maximizing patient comfort.
EMED recognizes the importance of partnering with leaders who have strategic advantages in their markets. For this reason, EMED offers infusion technology platforms to the pharmaceutical industry that can be tailored to meet specific clinical protocols.
EMED markets its devices under specific brand names through its international distribution networks. Our disruptive technology has earned EMED its international presence.
Thinking outside the box
EMED promotes corporate responsibility through environmental, social, and governance means in addition to its core commitment of improving patients' lives through infusion therapy.
Research & Development
EMED has designed and developed over 100 million medical devices that contribute to the
well-being of patients.
EMED has secured 10 patents and continues to develop additional
EMED invests increasing amounts of capital year over year to be at the forefront of research and to improve infusion technology
based on patient needs.
1. Data based on internal customer surveys from 2017-2019
2. Data based on internal customer survey from 2017
3. Based on bench testing (MM-057)